VEGFA and type 1 diabetes mellitus: These discoveries offer potential therapeutic targets for developing novel drugs or gene therapy techniques, such as vascular endothelial growth factor gene therapy, which can accelerate the formation of new blood vessels in CAD and T1DM patients [48,49].